Results 181 to 190 of about 18,339,616 (353)

Disease‐Stage Synchronized Nanozyme Therapy for Polymicrobial Sepsis through Adaptive Catalytic and Immune Reprogramming

open access: yesAdvanced Science, EarlyView.
A disease‐stage synchronized nanozyme platform is developed to treat polymicrobial sepsis by adapting its functions to changing infection environments. The system eliminates multidrug‐resistant bacteria during early infection while reducing inflammation and restoring immune balance during recovery, providing an integrated strategy for infection control
Anlai Zou   +11 more
wiley   +1 more source

Worsening of cerebral hyperemia by the administration of terlipressin in acute liver failure with severe hepatic encephalopathy [PDF]

open access: yes, 2004
There is increasing evidence that terlipressin is useful in patients with cirrhosis and hepatorenal syndrome, but there are no data of its use in patients with acute liver failure (ALF) in whom hepatorenal syndrome is common.
Jalan, R.   +6 more
core  

Dual pKa Lipid Nanoparticles for Lung‐tropic mRNA Delivery and pH‐Programmed Endosomal Escape

open access: yesAdvanced Science, EarlyView.
Lipid nanoparticles’ bottleneck lies in low endosomal escape efficiency and liver‐dominant delivery after intravenous administration. To overcome these limitations, we present a stepwise pH‐programmed lipid nanoparticle system enabled by our newly synthesized ionizable lipid.
Seong Gi Lim   +12 more
wiley   +1 more source

Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma

open access: yesAdvanced Science, EarlyView.
This review evaluates nanoparticle‐based phototherapies for uveal melanoma, highlighting emerging strategies to enhance tumor targeting, light delivery, and treatment precision. Preclinical data indicate improved efficacy and reduced toxicity, supporting their potential to enhance localized treatment and future translational advances. (Generated by the
Emilie Lambert   +8 more
wiley   +1 more source

OAF Blocks SIAH1‐Mediated Degradation of SCPX, a Therapeutic Strategy for MASLD

open access: yesAdvanced Science, EarlyView.
This study shows OAF directly binds to SCPX and inhibits its interaction with the E3 ligase SIAH1, thereby protecting SCPX from ubiquitin‐dependent degradation and stabilizing its levels. This OAF‐SCPX axis represents a novel pathway in lipid homeostasis, highlighting OAF as a promising therapeutic candidate for MASLD.
Zongxi Li   +11 more
wiley   +1 more source

Am J Obstet Gynecol [PDF]

open access: yes
OBJECTIVEWhile pregnancy-related severe liver disorders are rare, when they occur morbidity and mortality rates are increased for mothers and infants.

core  

Primer caso de platinosomosis en Colombia: Platynosomum illiciens (Digenea: Dicrocoeliidae) en Felis catus, Turbo, Antioquia Primeiro caso da platinosomosis na Colombia: Platynosomum illiciens (Digenea: Dicrocoeliidae) em Felis Catus, Turbo, Antioquia First case of platinosomosis from Colombia: Platynosomum illiciens (Digenea: Dicrocoeliidae) in Felis Catus, Turbo, Antioquia

open access: yesRevista Colombiana de Ciencias Pecuarias, 2009
La platinosomosis es una enfermedad hepática causada por digéneos del género Platynosomum Looss, 1907, que afecta aves y mamíferos de áreas tropicales y subtropicales.
Carolina Lenis   +2 more
doaj  

Home - About - Disclaimer - Privacy